However, TriKEs composed of one scFv against CD16, another against CD33 and a human IL-15 crosslinker promote NK cell effector functions, and also increase NK cell expansion and persistence in vivo in mouse preclinical models of AML and ovarian cancer (184, 185). Here, FCGR3A is linked to ovarian carcinoma.